MRNA基因表达蛋白质To investigate p120 catenin mRNA expression in Non-Hodgkin's lymphoma (NHL) cell lines (U937, Raji, Jurkat and Molt4) and normal lymphocytes and explore the relationship between p120 catenin and Non-Hodgkin's lymphoma, total RNA sample was extracted by using TRIzol and ...
TheAnaplastic Lymphoma Kinase(ALK) was originally identified in Anaplastic Large-Cell non-Hodgkin's Lymphoma (ALCL) cell lines as the product of achromosomal translocationt(2;5; p23;q35) involving theNucleophosmin(NPM1) partner[8,9]. The humanALKlocus is located at the 2p23.2–p23.1chromosome...
Non-Hodgkin lymphoma (NHL), the most common hematological malignancy in the world [1,2], mainly (about 86% of NHL) originates from B cells [3]. B-cell NHL (B-NHL) comprises over 40 main subtypes, such as diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), mantle cell l...
Non-Hodgkin lymphoma is a cancer of the lymphatic system. The lymphatic system contains lymph vessels, lymph nodes, and glands, such as the spleen and thymus. Lymph vessels carry lymph fluid throughout the body. Lymph fluid contains lymphocytes (white blood cells) that help fight infection and...
Cutaneous T-cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that affects the skin. Here authors show that CDK9 degradation of retinoic acid receptor α is a vulnerability for CTCL and develop a degrader targeting CDK9 that synergizes with all-trans retinoic acid to reduce CTCL ...
AIDS-related non-Hodgkin's lymphoma (AIDS-NHL) is the second most frequent cancer associated with AIDS, and is a frequent cause of death in HIV-infected individuals. Experimental analysis of AIDS-NHL has been facilitated by the availability of an excelle
B-cell non-Hodgkin lymphoma (B-NHL) is the most common type of lymphoma and is significantly heterogeneous among various subtypes. Despite of considerable advancements in treatment strategies for B-NHL, the prognosis of relapsed/refractory patients remai
B-cell non-Hodgkin lymphoma (NHL) collectively represents the most common type of hematologic malignancy [1]. While advances in chemotherapy, monoclonal antibodies, and stem cell transplantation have improved survival rates, many NHL patients remain resistant to therapy or experience relapse. This highl...
Survivin—An attractive target for RNAi in non-Hodgkin’s lymphoma, Daudi cell line as a model[J] . Gu Congmin,Zeng Mu,Ma Yihui,Lin Hanliang.Leukemia & Lymphoma . 2006 (9)Congmin G, Mu Z, Yihui M, Hanliang L: Survivin-an attractive target for RNAi in non-Hodgkin's lymphoma, ...
Klein E, Klein G, Nadkarni JS, et al. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res 1968; 28: 1300–10 PubMedCAS Milstein C, Cuello AC. Hybrid hybridomas and their use in immunohistochemistry. Nature 1983; 305: 537–41 ...